Log In
Print
BCIQ
Print
Print this Print this
 

AGT-181

  Manage Alerts
Collapse Summary General Information
Company ArmaGen Inc.
DescriptionRe-engineered human iduronidase (IDUA), where the lysosomal enzyme is fused to IgG, a mAb
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today